老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vor Biopharma Inc.

23.51
+1.215.43%
成交量：31.98萬
成交額：737.81萬
市值：13.91億
市盈率：2.04
高：23.56
開：22.39
低：22.27
收：22.30
52周最高：49.95
52周最低：6.50
股本：5,916.23萬
流通股本：3,723.34萬
量比：1.01
換手率：0.86%
股息：- -
股息率：- -
每股收益(TTM):11.53
每股收益(LYR):-70.5015
淨資產收益率：-125.43%
總資產收益率：-21.37%
市淨率：-6.95
市盈率(LYR):-0.33

資料載入中...

總覽公司新聞資訊公告
2021/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/17

重要事件披露

8-K - Current report
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/19

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/09

重要事件披露

8-K - Current report
2021/02/03

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/02/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/15

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/15

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933